Baloxavir (Synonyms: BXA, S-033447) |
| カタログ番号GC19055 |
プロドラッグのバロキサビル マルボキシルに由来するバロキサビル (バロキサビル酸) は、インフルエンザ A および B ウイルスのポリメラーゼ PA サブユニット内のクラス初の強力かつ選択的なキャップ依存性エンドヌクレアーゼ (CEN) 阻害剤です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1985605-59-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Baloxavir is an anti-influenza agent extracted from patent WO 2017104691 A1.
References:
[1]. Shishido Takao, et al. Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug. WO 2017104691 A1.
Average Rating: 5 (Based on Reviews and 21 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *